Brian J Blaser is Executive Vice President of ABBOTT LABORATORIES. Currently has a direct ownership of 130,745 shares of ABT, which is worth approximately $15.5 Million. The most recent transaction as insider was on May 23, 2019, when has been sold 450,062 shares (Common shares without par value) at a price of $75.52 per share, resulting in proceeds of $33,988,681. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 131K
0% 3M change
0% 12M change
Total Value Held $15.5 Million

Brian J Blaser Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 23 2019
SELL
Open market or private sale
$33,988,681 $75.52 p/Share
450,062 Reduced 77.49%
130,745 Common shares without ...
May 23 2019
BUY
Exercise of conversion of derivative security
$17,943,971 $39.87 p/Share
450,062 Added 43.66%
580,807 Common shares without ...
Mar 01 2019
SELL
Open market or private sale
$1,263,806 $78.23 p/Share
16,155 Reduced 11.0%
130,745 Common shares without ...
Feb 28 2019
SELL
Payment of exercise price or tax liability
$1,132,424 $77.23 p/Share
14,663 Reduced 9.08%
146,900 Common shares without ...
Feb 22 2019
BUY
Grant, award, or other acquisition
-
28,405 Added 14.95%
161,563 Common shares without ...
Dec 21 2018
SELL
Bona fide gift
-
60 Reduced 0.05%
133,158 Common shares without ...
Dec 20 2018
SELL
Bona fide gift
-
3,600 Reduced 2.63%
133,218 Common shares without ...
Sep 20 2018
SELL
Open market or private sale
$4,003,578 $68.79 p/Share
58,200 Reduced 29.84%
136,818 Common shares without ...
Sep 20 2018
BUY
Exercise of conversion of derivative security
$1,638,912 $28.16 p/Share
58,200 Added 22.98%
195,018 Common shares without ...
Jul 24 2018
SELL
Open market or private sale
$965,494 $63.94 p/Share
15,100 Reduced 9.94%
136,818 Common shares without ...
Feb 28 2018
SELL
Payment of exercise price or tax liability
$819,181 $60.55 p/Share
13,529 Reduced 8.18%
151,918 Common shares without ...
Feb 16 2018
BUY
Grant, award, or other acquisition
-
36,593 Added 18.11%
165,447 Common shares without ...
Jan 31 2018
SELL
Open market or private sale
$1,726,657 $62.26 p/Share
27,733 Reduced 17.71%
128,854 Common shares without ...
Jan 31 2018
BUY
Exercise of conversion of derivative security
$620,942 $22.39 p/Share
27,733 Added 15.05%
156,587 Common shares without ...
Nov 17 2017
SELL
Open market or private sale
$1,325,756 $55.55 p/Share
23,866 Reduced 15.63%
128,854 Common shares without ...
Nov 17 2017
BUY
Exercise of conversion of derivative security
$236,376 $24.71 p/Share
9,566 Added 5.89%
152,720 Common shares without ...
Jul 27 2017
SELL
Open market or private sale
$750,000 $50.0 p/Share
15,000 Reduced 9.48%
143,154 Common shares without ...
Feb 28 2017
SELL
Payment of exercise price or tax liability
$602,754 $45.46 p/Share
13,259 Reduced 7.74%
158,154 Common shares without ...
Feb 17 2017
BUY
Grant, award, or other acquisition
-
26,351 Added 13.32%
171,413 Common shares without ...
Dec 20 2016
BUY
Open market or private purchase
$598,895 $38.44 p/Share
15,580 Added 9.7%
145,062 Common shares without ...
Feb 29 2016
SELL
Open market or private sale
$60,624 $39.29 p/Share
1,543 Reduced 1.18%
129,482 Common shares without ...
Feb 29 2016
SELL
Payment of exercise price or tax liability
$468,668 $39.52 p/Share
11,859 Reduced 8.3%
131,025 Common shares without ...
Feb 19 2016
BUY
Grant, award, or other acquisition
-
40,690 Added 22.17%
142,884 Common shares without ...

Also insider at

RKLY
Rockley Photonics Holdings Ltd Technology
TLIS
Talis Biomedical Corp Healthcare
QTRX
Quanterix Corp Healthcare
BJB

Brian J Blaser

Executive Vice President
Abbott Park, IL

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT